Gouzoulis-Mayfrank et al. (1999) performed a double-blind, placebo-controlled PET study using [18F]FDG to examine the neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE), and D-methamphetamine in healthy volunteers.

Authors

• Person: Not available Organization: Nature
  Neuroimaging in psychedelic drug development: past, present, and ...
• Person: David B Yaden, Matthew W Johnson, Roland R Griffiths, Manoj K Doss, Albert Garcia-Romeu, Sandeep Nayak, Natalie Gukasyan, Brian N Mathur, Frederick S Barrett Organization: Oxford University Press
  Psychedelics and Consciousness: Distinctions, Demarcations, and ...

Sources

• Neuroimaging in psychedelic drug development: past, present, and ... www.nature.com Nature via serper
• Psychedelics and Consciousness: Distinctions, Demarcations, and ... ouci.dntb.gov.ua David B Yaden, Matthew W Johnson, Roland R Griffiths, Manoj K Doss, Albert Garcia-Romeu, Sandeep Nayak, Natalie Gukasyan, Brian N Mathur, Frederick S Barrett · Oxford University Press via serper

Referenced by nodes (1)

• psilocybin concept